• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS, INC. VITROS IMMUNODIAGNOSTIC PRODUCTS HBSAG REAGENT PACK; IN-VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS, INC. VITROS IMMUNODIAGNOSTIC PRODUCTS HBSAG REAGENT PACK; IN-VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6801322
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/14/2023
Event Type  malfunction  
Event Description
A customer contacted the ortho clinical diagnostics (ortho) technical solution center (tsc) to report false negative vitros hbsag results were obtained when tested using non-vitros external quality assessment (eqa) proficiency fluids when using vitros hbsag reagent lot 3460 on a vitros 3600 immunodiagnostic system.Eqa sample 231h-12 results of 0.07 and 0.08 (non-reactive) s/c vs.Expected result of 2.23 and 2.35 s/c (reactive).Eqa sample 231h-16 results of 0.19 and 0.18 (non-reactive) s/c vs.Expected result of 1.69 and 1.78 s/c(reactive).Eqa sample 231h-20 results of 0.57 and 0.60 (non-reactive) s/c vs.Expected result of 3.58 and 3.78 s/c (reactive).Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The false negative vitros hbsag results were obtained from a non-patient fluid.The customer did not indicate that any unexpected vitros hbsag results were obtained for patient samples at the time of the event or over the course of the investigation and there are no reported allegations of patient harm.This report corresponds to ortho clinical diagnostics inc (ortho) complaint number (b)(4) and reportability assessment (b)(4).
 
Manufacturer Narrative
The investigation determined that false negative vitros hbsag results were obtained when tested using non-vitros external quality assessment (eqa) proficiency fluids when using vitros hbsag reagent lot 3460 on a vitros 3600 immunodiagnostic system.A definite assignable cause of the event cannot be determined.A potential contributor to the event was the calibration in use.A review of vitros hbsag reagent lot 3460 calibrations identified that the false negative vitros hbsag results were processed on a calibration that had expired 2 months prior.No precision testing was performed on the vitros 3600 immunodiagnostic system at the time of the event; therefore, an instrument related issue cannot be entirely ruled out as a contributor of the events.However, historical vitros qc fluid results were precise, and no evidence of any instrument malfunction was reported.The proficiency samples were from blood bags.Sample handling and storage of the proficiency samples is a possible contributor to the event as it was not determined if the customer was following the eqa ifu recommendation for sample handling and storage.Furthermore, the presence of an unknown sample interferent that affects the vitros hbsag method and not the non-vitros hbsag method cannot be ruled out as contributing to this event.The vitros hbsag ifu states ¿a negative test result does not exclude the possibility of exposure to or infection with hepatitis b virus.Levels of hbsag may be undetectable both in early infection and late after infection.In rare cases hbsag tests do not detect certain hbv mutant strains.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS HBSAG REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS, INC.
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO-CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
laurie o'riordan
microtyping systems
1295 southwest 29th avenue
pompano beach, FL 33069
9549709500
MDR Report Key18104573
MDR Text Key329329014
Report Number3007111389-2023-00196
Device Sequence Number1
Product Code LOM
UDI-Device Identifier10758750001064
UDI-Public10758750001064
Combination Product (y/n)N
Reporter Country CodeVM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/24/2024
Device Catalogue Number6801322
Device Lot Number3460
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/18/2023
Initial Date FDA Received11/09/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/02/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-